nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Body temperature increased—Dactinomycin—kidney cancer	0.00054	0.00054	CcSEcCtD
Meropenem—Asthenia—Sorafenib—kidney cancer	0.000538	0.000538	CcSEcCtD
Meropenem—Malaise—Paclitaxel—kidney cancer	0.000536	0.000536	CcSEcCtD
Meropenem—Hypoglycaemia—Doxorubicin—kidney cancer	0.000535	0.000535	CcSEcCtD
Meropenem—Cardiac failure—Doxorubicin—kidney cancer	0.000535	0.000535	CcSEcCtD
Meropenem—Syncope—Paclitaxel—kidney cancer	0.000533	0.000533	CcSEcCtD
Meropenem—Leukopenia—Paclitaxel—kidney cancer	0.000532	0.000532	CcSEcCtD
Meropenem—Hypersensitivity—Sunitinib—kidney cancer	0.000532	0.000532	CcSEcCtD
Meropenem—Decreased appetite—Vincristine—kidney cancer	0.000531	0.000531	CcSEcCtD
Meropenem—Pruritus—Sorafenib—kidney cancer	0.000531	0.000531	CcSEcCtD
Meropenem—Vomiting—Erlotinib—kidney cancer	0.00053	0.00053	CcSEcCtD
Meropenem—Erythema multiforme—Capecitabine—kidney cancer	0.00053	0.00053	CcSEcCtD
Meropenem—Gastrointestinal disorder—Vincristine—kidney cancer	0.000527	0.000527	CcSEcCtD
Meropenem—Rash—Erlotinib—kidney cancer	0.000526	0.000526	CcSEcCtD
Meropenem—Dermatitis—Erlotinib—kidney cancer	0.000525	0.000525	CcSEcCtD
Meropenem—Insomnia—Gemcitabine—kidney cancer	0.000524	0.000524	CcSEcCtD
Meropenem—Headache—Erlotinib—kidney cancer	0.000523	0.000523	CcSEcCtD
Meropenem—Loss of consciousness—Paclitaxel—kidney cancer	0.000522	0.000522	CcSEcCtD
Meropenem—Pain—Vincristine—kidney cancer	0.000522	0.000522	CcSEcCtD
Meropenem—Constipation—Vincristine—kidney cancer	0.000522	0.000522	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000522	0.000522	CcSEcCtD
Meropenem—Paraesthesia—Gemcitabine—kidney cancer	0.00052	0.00052	CcSEcCtD
Meropenem—Cough—Paclitaxel—kidney cancer	0.000519	0.000519	CcSEcCtD
Meropenem—Asthenia—Sunitinib—kidney cancer	0.000518	0.000518	CcSEcCtD
Meropenem—Dyspnoea—Gemcitabine—kidney cancer	0.000517	0.000517	CcSEcCtD
Meropenem—Nausea—Vinblastine—kidney cancer	0.000515	0.000515	CcSEcCtD
Meropenem—Somnolence—Gemcitabine—kidney cancer	0.000515	0.000515	CcSEcCtD
Meropenem—Nausea—Everolimus—kidney cancer	0.000513	0.000513	CcSEcCtD
Meropenem—Diarrhoea—Sorafenib—kidney cancer	0.000513	0.000513	CcSEcCtD
Meropenem—Hypertension—Paclitaxel—kidney cancer	0.000513	0.000513	CcSEcCtD
Meropenem—Pruritus—Sunitinib—kidney cancer	0.000511	0.000511	CcSEcCtD
Meropenem—Immune system disorder—Capecitabine—kidney cancer	0.000506	0.000506	CcSEcCtD
Meropenem—Chest pain—Paclitaxel—kidney cancer	0.000506	0.000506	CcSEcCtD
Meropenem—Anxiety—Paclitaxel—kidney cancer	0.000504	0.000504	CcSEcCtD
Meropenem—Decreased appetite—Gemcitabine—kidney cancer	0.000504	0.000504	CcSEcCtD
Meropenem—Hypersensitivity—Dactinomycin—kidney cancer	0.000504	0.000504	CcSEcCtD
Meropenem—Chills—Capecitabine—kidney cancer	0.000503	0.000503	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000503	0.000503	CcSEcCtD
Meropenem—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.0005	0.0005	CcSEcCtD
Meropenem—Gastrointestinal pain—Vincristine—kidney cancer	0.000499	0.000499	CcSEcCtD
Meropenem—Cardiac arrest—Doxorubicin—kidney cancer	0.000496	0.000496	CcSEcCtD
Meropenem—Dizziness—Sorafenib—kidney cancer	0.000496	0.000496	CcSEcCtD
Meropenem—Constipation—Gemcitabine—kidney cancer	0.000495	0.000495	CcSEcCtD
Meropenem—Pain—Gemcitabine—kidney cancer	0.000495	0.000495	CcSEcCtD
Meropenem—Nausea—Erlotinib—kidney cancer	0.000495	0.000495	CcSEcCtD
Meropenem—Diarrhoea—Sunitinib—kidney cancer	0.000494	0.000494	CcSEcCtD
Meropenem—Asthenia—Dactinomycin—kidney cancer	0.00049	0.00049	CcSEcCtD
Meropenem—Confusional state—Paclitaxel—kidney cancer	0.000489	0.000489	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—kidney cancer	0.000489	0.000489	CcSEcCtD
Meropenem—Erythema—Capecitabine—kidney cancer	0.000488	0.000488	CcSEcCtD
Meropenem—Oedema—Paclitaxel—kidney cancer	0.000485	0.000485	CcSEcCtD
Meropenem—Anaphylactic shock—Paclitaxel—kidney cancer	0.000485	0.000485	CcSEcCtD
Meropenem—Abdominal pain—Vincristine—kidney cancer	0.000483	0.000483	CcSEcCtD
Meropenem—Body temperature increased—Vincristine—kidney cancer	0.000483	0.000483	CcSEcCtD
Meropenem—Infection—Paclitaxel—kidney cancer	0.000482	0.000482	CcSEcCtD
Meropenem—Flatulence—Capecitabine—kidney cancer	0.000481	0.000481	CcSEcCtD
Meropenem—Dysgeusia—Capecitabine—kidney cancer	0.000478	0.000478	CcSEcCtD
Meropenem—Dizziness—Sunitinib—kidney cancer	0.000477	0.000477	CcSEcCtD
Meropenem—Feeling abnormal—Gemcitabine—kidney cancer	0.000477	0.000477	CcSEcCtD
Meropenem—Shock—Paclitaxel—kidney cancer	0.000477	0.000477	CcSEcCtD
Meropenem—Vomiting—Sorafenib—kidney cancer	0.000477	0.000477	CcSEcCtD
Meropenem—Nervous system disorder—Paclitaxel—kidney cancer	0.000476	0.000476	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—kidney cancer	0.000475	0.000475	CcSEcCtD
Meropenem—Thrombocytopenia—Paclitaxel—kidney cancer	0.000475	0.000475	CcSEcCtD
Meropenem—Tachycardia—Paclitaxel—kidney cancer	0.000473	0.000473	CcSEcCtD
Meropenem—Rash—Sorafenib—kidney cancer	0.000473	0.000473	CcSEcCtD
Meropenem—Dermatitis—Sorafenib—kidney cancer	0.000473	0.000473	CcSEcCtD
Meropenem—Back pain—Capecitabine—kidney cancer	0.000472	0.000472	CcSEcCtD
Meropenem—Skin disorder—Paclitaxel—kidney cancer	0.000471	0.000471	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00047	0.00047	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00047	0.00047	CcSEcCtD
Meropenem—Headache—Sorafenib—kidney cancer	0.00047	0.00047	CcSEcCtD
Meropenem—Hyperhidrosis—Paclitaxel—kidney cancer	0.000469	0.000469	CcSEcCtD
Meropenem—Diarrhoea—Dactinomycin—kidney cancer	0.000468	0.000468	CcSEcCtD
Meropenem—Anorexia—Paclitaxel—kidney cancer	0.000462	0.000462	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00046	0.00046	CcSEcCtD
Meropenem—Vomiting—Sunitinib—kidney cancer	0.000459	0.000459	CcSEcCtD
Meropenem—Body temperature increased—Gemcitabine—kidney cancer	0.000458	0.000458	CcSEcCtD
Meropenem—Rash—Sunitinib—kidney cancer	0.000455	0.000455	CcSEcCtD
Meropenem—Dermatitis—Sunitinib—kidney cancer	0.000455	0.000455	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—kidney cancer	0.000454	0.000454	CcSEcCtD
Meropenem—Hypotension—Paclitaxel—kidney cancer	0.000453	0.000453	CcSEcCtD
Meropenem—Headache—Sunitinib—kidney cancer	0.000452	0.000452	CcSEcCtD
Meropenem—Asthma—Doxorubicin—kidney cancer	0.000451	0.000451	CcSEcCtD
Meropenem—Anaemia—Capecitabine—kidney cancer	0.000451	0.000451	CcSEcCtD
Meropenem—Hypersensitivity—Vincristine—kidney cancer	0.00045	0.00045	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—kidney cancer	0.000447	0.000447	CcSEcCtD
Meropenem—Nausea—Sorafenib—kidney cancer	0.000446	0.000446	CcSEcCtD
Meropenem—Malaise—Capecitabine—kidney cancer	0.00044	0.00044	CcSEcCtD
Meropenem—Insomnia—Paclitaxel—kidney cancer	0.000439	0.000439	CcSEcCtD
Meropenem—Asthenia—Vincristine—kidney cancer	0.000438	0.000438	CcSEcCtD
Meropenem—Syncope—Capecitabine—kidney cancer	0.000437	0.000437	CcSEcCtD
Meropenem—Leukopenia—Capecitabine—kidney cancer	0.000437	0.000437	CcSEcCtD
Meropenem—Paraesthesia—Paclitaxel—kidney cancer	0.000436	0.000436	CcSEcCtD
Meropenem—Vomiting—Dactinomycin—kidney cancer	0.000435	0.000435	CcSEcCtD
Meropenem—Dyspnoea—Paclitaxel—kidney cancer	0.000432	0.000432	CcSEcCtD
Meropenem—Somnolence—Paclitaxel—kidney cancer	0.000431	0.000431	CcSEcCtD
Meropenem—Rash—Dactinomycin—kidney cancer	0.000431	0.000431	CcSEcCtD
Meropenem—Nausea—Sunitinib—kidney cancer	0.000429	0.000429	CcSEcCtD
Meropenem—Loss of consciousness—Capecitabine—kidney cancer	0.000429	0.000429	CcSEcCtD
Meropenem—Dyspepsia—Paclitaxel—kidney cancer	0.000427	0.000427	CcSEcCtD
Meropenem—Cough—Capecitabine—kidney cancer	0.000426	0.000426	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—kidney cancer	0.000422	0.000422	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—kidney cancer	0.000422	0.000422	CcSEcCtD
Meropenem—Decreased appetite—Paclitaxel—kidney cancer	0.000422	0.000422	CcSEcCtD
Meropenem—Hypertension—Capecitabine—kidney cancer	0.000421	0.000421	CcSEcCtD
Meropenem—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000419	0.000419	CcSEcCtD
Meropenem—Diarrhoea—Vincristine—kidney cancer	0.000418	0.000418	CcSEcCtD
Meropenem—Asthenia—Gemcitabine—kidney cancer	0.000416	0.000416	CcSEcCtD
Meropenem—Chest pain—Capecitabine—kidney cancer	0.000415	0.000415	CcSEcCtD
Meropenem—Constipation—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Meropenem—Pain—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Meropenem—Anxiety—Capecitabine—kidney cancer	0.000414	0.000414	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000412	0.000412	CcSEcCtD
Meropenem—Pruritus—Gemcitabine—kidney cancer	0.00041	0.00041	CcSEcCtD
Meropenem—Nausea—Dactinomycin—kidney cancer	0.000406	0.000406	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—kidney cancer	0.000405	0.000405	CcSEcCtD
Meropenem—Dizziness—Vincristine—kidney cancer	0.000404	0.000404	CcSEcCtD
Meropenem—Infestation—Doxorubicin—kidney cancer	0.000402	0.000402	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—kidney cancer	0.000402	0.000402	CcSEcCtD
Meropenem—Confusional state—Capecitabine—kidney cancer	0.000401	0.000401	CcSEcCtD
Meropenem—Feeling abnormal—Paclitaxel—kidney cancer	0.0004	0.0004	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000399	0.000399	CcSEcCtD
Meropenem—Oedema—Capecitabine—kidney cancer	0.000398	0.000398	CcSEcCtD
Meropenem—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000397	0.000397	CcSEcCtD
Meropenem—Diarrhoea—Gemcitabine—kidney cancer	0.000396	0.000396	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—kidney cancer	0.000396	0.000396	CcSEcCtD
Meropenem—Infection—Capecitabine—kidney cancer	0.000395	0.000395	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000394	0.000394	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—kidney cancer	0.000392	0.000392	CcSEcCtD
Meropenem—Shock—Capecitabine—kidney cancer	0.000392	0.000392	CcSEcCtD
Meropenem—Nervous system disorder—Capecitabine—kidney cancer	0.00039	0.00039	CcSEcCtD
Meropenem—Thrombocytopenia—Capecitabine—kidney cancer	0.00039	0.00039	CcSEcCtD
Meropenem—Tachycardia—Capecitabine—kidney cancer	0.000389	0.000389	CcSEcCtD
Meropenem—Vomiting—Vincristine—kidney cancer	0.000388	0.000388	CcSEcCtD
Meropenem—Skin disorder—Capecitabine—kidney cancer	0.000387	0.000387	CcSEcCtD
Meropenem—Sweating—Doxorubicin—kidney cancer	0.000386	0.000386	CcSEcCtD
Meropenem—Urticaria—Paclitaxel—kidney cancer	0.000385	0.000385	CcSEcCtD
Meropenem—Rash—Vincristine—kidney cancer	0.000385	0.000385	CcSEcCtD
Meropenem—Hyperhidrosis—Capecitabine—kidney cancer	0.000385	0.000385	CcSEcCtD
Meropenem—Dermatitis—Vincristine—kidney cancer	0.000385	0.000385	CcSEcCtD
Meropenem—Abdominal pain—Paclitaxel—kidney cancer	0.000383	0.000383	CcSEcCtD
Meropenem—Body temperature increased—Paclitaxel—kidney cancer	0.000383	0.000383	CcSEcCtD
Meropenem—Headache—Vincristine—kidney cancer	0.000383	0.000383	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000381	0.000381	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—kidney cancer	0.000379	0.000379	CcSEcCtD
Meropenem—Anorexia—Capecitabine—kidney cancer	0.000379	0.000379	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—kidney cancer	0.000375	0.000375	CcSEcCtD
Meropenem—Hypotension—Capecitabine—kidney cancer	0.000372	0.000372	CcSEcCtD
Meropenem—Vomiting—Gemcitabine—kidney cancer	0.000368	0.000368	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—kidney cancer	0.000368	0.000368	CcSEcCtD
Meropenem—Rash—Gemcitabine—kidney cancer	0.000365	0.000365	CcSEcCtD
Meropenem—Dermatitis—Gemcitabine—kidney cancer	0.000365	0.000365	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—kidney cancer	0.000363	0.000363	CcSEcCtD
Meropenem—Headache—Gemcitabine—kidney cancer	0.000363	0.000363	CcSEcCtD
Meropenem—Nausea—Vincristine—kidney cancer	0.000363	0.000363	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—kidney cancer	0.000361	0.000361	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—kidney cancer	0.000361	0.000361	CcSEcCtD
Meropenem—Insomnia—Capecitabine—kidney cancer	0.00036	0.00036	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—kidney cancer	0.000358	0.000358	CcSEcCtD
Meropenem—Paraesthesia—Capecitabine—kidney cancer	0.000357	0.000357	CcSEcCtD
Meropenem—Hypersensitivity—Paclitaxel—kidney cancer	0.000357	0.000357	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—kidney cancer	0.000356	0.000356	CcSEcCtD
Meropenem—Dyspnoea—Capecitabine—kidney cancer	0.000355	0.000355	CcSEcCtD
Meropenem—Dyspepsia—Capecitabine—kidney cancer	0.00035	0.00035	CcSEcCtD
Meropenem—Asthenia—Paclitaxel—kidney cancer	0.000348	0.000348	CcSEcCtD
Meropenem—Decreased appetite—Capecitabine—kidney cancer	0.000346	0.000346	CcSEcCtD
Meropenem—Nausea—Gemcitabine—kidney cancer	0.000344	0.000344	CcSEcCtD
Meropenem—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000344	0.000344	CcSEcCtD
Meropenem—Pruritus—Paclitaxel—kidney cancer	0.000343	0.000343	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—kidney cancer	0.000342	0.000342	CcSEcCtD
Meropenem—Pain—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Meropenem—Constipation—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Meropenem—Diarrhoea—Paclitaxel—kidney cancer	0.000332	0.000332	CcSEcCtD
Meropenem—Feeling abnormal—Capecitabine—kidney cancer	0.000328	0.000328	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—kidney cancer	0.000326	0.000326	CcSEcCtD
Meropenem—Gastrointestinal pain—Capecitabine—kidney cancer	0.000326	0.000326	CcSEcCtD
Meropenem—Chills—Doxorubicin—kidney cancer	0.000324	0.000324	CcSEcCtD
Meropenem—Dizziness—Paclitaxel—kidney cancer	0.000321	0.000321	CcSEcCtD
Meropenem—Urticaria—Capecitabine—kidney cancer	0.000316	0.000316	CcSEcCtD
Meropenem—Body temperature increased—Capecitabine—kidney cancer	0.000315	0.000315	CcSEcCtD
Meropenem—Abdominal pain—Capecitabine—kidney cancer	0.000315	0.000315	CcSEcCtD
Meropenem—Erythema—Doxorubicin—kidney cancer	0.000314	0.000314	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—kidney cancer	0.00031	0.00031	CcSEcCtD
Meropenem—Tension—Doxorubicin—kidney cancer	0.000309	0.000309	CcSEcCtD
Meropenem—Vomiting—Paclitaxel—kidney cancer	0.000308	0.000308	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—kidney cancer	0.000308	0.000308	CcSEcCtD
Meropenem—Rash—Paclitaxel—kidney cancer	0.000306	0.000306	CcSEcCtD
Meropenem—Dermatitis—Paclitaxel—kidney cancer	0.000306	0.000306	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—kidney cancer	0.000305	0.000305	CcSEcCtD
Meropenem—Back pain—Doxorubicin—kidney cancer	0.000304	0.000304	CcSEcCtD
Meropenem—Headache—Paclitaxel—kidney cancer	0.000304	0.000304	CcSEcCtD
Meropenem—Hypersensitivity—Capecitabine—kidney cancer	0.000293	0.000293	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—kidney cancer	0.000291	0.000291	CcSEcCtD
Meropenem—Agitation—Doxorubicin—kidney cancer	0.000289	0.000289	CcSEcCtD
Meropenem—Nausea—Paclitaxel—kidney cancer	0.000288	0.000288	CcSEcCtD
Meropenem—Asthenia—Capecitabine—kidney cancer	0.000286	0.000286	CcSEcCtD
Meropenem—Malaise—Doxorubicin—kidney cancer	0.000284	0.000284	CcSEcCtD
Meropenem—Syncope—Doxorubicin—kidney cancer	0.000282	0.000282	CcSEcCtD
Meropenem—Pruritus—Capecitabine—kidney cancer	0.000282	0.000282	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—kidney cancer	0.000281	0.000281	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—kidney cancer	0.000276	0.000276	CcSEcCtD
Meropenem—Cough—Doxorubicin—kidney cancer	0.000274	0.000274	CcSEcCtD
Meropenem—Diarrhoea—Capecitabine—kidney cancer	0.000272	0.000272	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—kidney cancer	0.000271	0.000271	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—kidney cancer	0.000268	0.000268	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—kidney cancer	0.000267	0.000267	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000266	0.000266	CcSEcCtD
Meropenem—Dizziness—Capecitabine—kidney cancer	0.000263	0.000263	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—kidney cancer	0.000259	0.000259	CcSEcCtD
Meropenem—Oedema—Doxorubicin—kidney cancer	0.000257	0.000257	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—kidney cancer	0.000257	0.000257	CcSEcCtD
Meropenem—Infection—Doxorubicin—kidney cancer	0.000255	0.000255	CcSEcCtD
Meropenem—Vomiting—Capecitabine—kidney cancer	0.000253	0.000253	CcSEcCtD
Meropenem—Shock—Doxorubicin—kidney cancer	0.000252	0.000252	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—kidney cancer	0.000252	0.000252	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—kidney cancer	0.000251	0.000251	CcSEcCtD
Meropenem—Rash—Capecitabine—kidney cancer	0.000251	0.000251	CcSEcCtD
Meropenem—Dermatitis—Capecitabine—kidney cancer	0.000251	0.000251	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—kidney cancer	0.00025	0.00025	CcSEcCtD
Meropenem—Headache—Capecitabine—kidney cancer	0.000249	0.000249	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—kidney cancer	0.000249	0.000249	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—kidney cancer	0.000248	0.000248	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—kidney cancer	0.000245	0.000245	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—kidney cancer	0.00024	0.00024	CcSEcCtD
Meropenem—Nausea—Capecitabine—kidney cancer	0.000236	0.000236	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—kidney cancer	0.000232	0.000232	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—kidney cancer	0.00023	0.00023	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—kidney cancer	0.000229	0.000229	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—kidney cancer	0.000228	0.000228	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—kidney cancer	0.000226	0.000226	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—kidney cancer	0.000223	0.000223	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000222	0.000222	CcSEcCtD
Meropenem—Constipation—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Meropenem—Pain—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—kidney cancer	0.000211	0.000211	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00021	0.00021	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—kidney cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—kidney cancer	0.000203	0.000203	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—kidney cancer	0.000203	0.000203	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—kidney cancer	0.000189	0.000189	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—kidney cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—kidney cancer	0.000182	0.000182	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—kidney cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—kidney cancer	0.00017	0.00017	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—kidney cancer	0.000163	0.000163	CcSEcCtD
Meropenem—Rash—Doxorubicin—kidney cancer	0.000162	0.000162	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—kidney cancer	0.000162	0.000162	CcSEcCtD
Meropenem—Headache—Doxorubicin—kidney cancer	0.000161	0.000161	CcSEcCtD
Meropenem—Nausea—Doxorubicin—kidney cancer	0.000152	0.000152	CcSEcCtD
